Sex differences in HIV infection

EP Scully - Current HIV/AIDS Reports, 2018 - Springer
Abstract Purpose of Review This review will outline the multilevel effects of biological sex on
HIV acquisition, pathogenesis, treatment response, and prospects for cure. Potential …

Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications

V Avettand-Fènoël, L Hocqueloux… - Clinical microbiology …, 2016 - Am Soc Microbiol
SUMMARY HIV-1 DNA persists in infected cells despite combined antiretroviral therapy
(cART), forming viral reservoirs. Recent trials of strategies targeting latent HIV reservoirs …

HIV DNA set point is rapidly established in acute HIV infection and dramatically reduced by early ART

J Ananworanich, N Chomont, LA Eller, E Kroon… - …, 2016 - thelancet.com
HIV DNA is a marker of HIV persistence that predicts HIV progression and remission, but its
kinetics in early acute HIV infection (AHI) is poorly understood. We longitudinally measured …

HIV-1 DNA predicts disease progression and post-treatment virological control

JP Williams, J Hurst, W Stöhr, N Robinson, H Brown… - elife, 2014 - elifesciences.org
In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite
antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might …

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

ES Gray, MC Madiga, T Hermanus, PL Moore… - Journal of …, 2011 - Am Soc Microbiol
An understanding of how broadly neutralizing activity develops in HIV-1-infected individuals
is needed to guide vaccine design and immunization strategies. Here we used a large panel …

Predictors of disease progression in HIV infection: a review

SE Langford, J Ananworanich, DA Cooper - AIDS research and therapy, 2007 - Springer
During the extended clinically latent period associated with Human Immunodeficiency Virus
(HIV) infection the virus itself is far from latent. This phase of infection generally comes to an …

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

JA Horwitz, A Halper-Stromberg… - Proceedings of the …, 2013 - National Acad Sciences
Effective control of HIV-1 infection in humans is achieved using combinations of antiretroviral
therapy (ART) drugs. In humanized mice (hu-mice), control of viremia can be achieved using …

Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression

L Roberts, JAS Passmore, C Williamson, F Little… - Aids, 2010 - journals.lww.com
Background: Both T-cell activation during early HIV-1 infection and soluble markers of
immune activation during chronic infection are predictive of HIV disease progression …

[HTML][HTML] Focus: Infectious diseases: Mechanisms of virologic control and clinical characteristics of HIV+ elite/viremic controllers

E Gonzalo-Gil, U Ikediobi, RE Sutton - The Yale journal of biology …, 2017 - ncbi.nlm.nih.gov
Human immunodeficiency virus type 1 (HIV-1) disease is pandemic, with approximately 36
million infected individuals world-wide. For the vast majority of these individuals, untreated …

Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection

AS Liovat, MA Rey-Cuillé, C Lécuroux, B Jacquelin… - 2012 - journals.plos.org
T cell activation levels, viral load and CD4+ T cell counts at early stages of HIV-1 infection
are predictive of the rate of progression towards AIDS. We evaluated whether the …